Literature DB >> 14673169

Role for BRG1 in cell cycle control and tumor suppression.

Kristin B Hendricks1, Frances Shanahan, Emma Lees.   

Abstract

Human BRG1, a subunit of the Swi/Snf chromatin remodeling apparatus, has been implicated in regulation of cellular proliferation and is a candidate tumor suppressor. Reintroduction of BRG1 into a breast tumor cell line, ALAB, carrying a defined mutation in the BRG1 gene, induced growth arrest. Gene expression data revealed that the arrest may in part be accounted for by down-regulation of select E2F target genes such as cyclin E, but more dramatically, by up-regulation of mRNAs for the cyclin-dependent kinase inhibitors p21 and p15. Protein levels of both p15 and p21 were induced, and p21 protein was recruited to a complex with cyclin-dependent kinase, CDK2, to inhibit its activity. BRG1 can associate with the p21 promoter in a p53-independent manner, suggesting that the induction of p21 by BRG1 may be direct. Further, using microarray and real-time PCR analysis we identified several novel BRG1-regulated genes. Our work provides further evidence for a role for BRG1 in the regulation of several genes involved in key steps in tumorigenesis and has revealed a potential mechanism for BRG1-induced growth arrest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14673169      PMCID: PMC303366          DOI: 10.1128/MCB.24.1.362-376.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

1.  Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.

Authors:  J A Biegel; J Y Zhou; L B Rorke; C Stenstrom; L M Wainwright; B Fogelgren
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

2.  Dissecting the regulatory circuitry of a eukaryotic genome.

Authors:  F C Holstege; E G Jennings; J J Wyrick; T I Lee; C J Hengartner; M R Green; T R Golub; E S Lander; R A Young
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

3.  Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB.

Authors:  J A Ranish; N Yudkovsky; S Hahn
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

4.  Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest.

Authors:  F Shanahan; W Seghezzi; D Parry; D Mahony; E Lees
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.

Authors:  Shilpa Kadam; Beverly M Emerson
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

6.  Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.

Authors:  D Parry; D Mahony; K Wills; E Lees
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha).

Authors:  J C Reyes; J Barra; C Muchardt; A Camus; C Babinet; M Yaniv
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

8.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.

Authors:  A Moustakas; D Kardassis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point.

Authors:  Christoph Schorl; John M Sedivy
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

10.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

View more
  76 in total

1.  SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.

Authors:  Min Zhang; Meng Chen; Ju-Ryoung Kim; Jiliang Zhou; Rebekah E Jones; Johnathan D Tune; Ghassan S Kassab; Daniel Metzger; Shawn Ahlfeld; Simon J Conway; B Paul Herring
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.

Authors:  Jin Bai; Peng-Jin Mei; Hui Liu; Chen Li; Wang Li; Yong-Ping Wu; Zheng-Quan Yu; Jun-Nian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-24       Impact factor: 4.553

Review 3.  E2F-associated chromatin modifiers and cell cycle control.

Authors:  Alexandre Blais; Brian D Dynlacht
Journal:  Curr Opin Cell Biol       Date:  2007-11-19       Impact factor: 8.382

4.  Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Authors:  Petar Jelinic; Jennifer J Mueller; Narciso Olvera; Fanny Dao; Sasinya N Scott; Ronak Shah; JianJiong Gao; Nikolaus Schultz; Mithat Gonen; Robert A Soslow; Michael F Berger; Douglas A Levine
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

5.  Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1.

Authors:  Helen Hoffmeister; Andreas Fuchs; Laura Strobl; Frank Sprenger; Regina Gröbner-Ferreira; Stefanie Michaelis; Petra Hoffmann; Julian Nazet; Rainer Merkl; Gernot Längst
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

6.  Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.

Authors:  Gregory R Hoffman; Rami Rahal; Frank Buxton; Kay Xiang; Gregory McAllister; Elizabeth Frias; Linda Bagdasarian; Janina Huber; Alicia Lindeman; Dongshu Chen; Rodrigo Romero; Nadire Ramadan; Tanushree Phadke; Kristy Haas; Mariela Jaskelioff; Boris G Wilson; Matthew J Meyer; Veronica Saenz-Vash; Huili Zhai; Vic E Myer; Jeffery A Porter; Nicholas Keen; Margaret E McLaughlin; Craig Mickanin; Charles W M Roberts; Frank Stegmeier; Zainab Jagani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

7.  Human SWI/SNF drives sequence-directed repositioning of nucleosomes on C-myc promoter DNA minicircles.

Authors:  Hillel I Sims; Jacqueline M Lane; Natalia P Ulyanova; Gavin R Schnitzler
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

8.  Molecular basis of CD4 repression by the Swi/Snf-like BAF chromatin remodeling complex.

Authors:  Mimi Wan; Jianmin Zhang; Dazhi Lai; Anant Jani; Paula Prestone-Hurlburt; Lulu Zhao; Aruna Ramachandran; Gavin R Schnitzler; Tian Chi
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

Review 9.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

10.  Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.

Authors:  Agnes Klochendler-Yeivin; Eli Picarsky; Moshe Yaniv
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.